...体表达的影响 - docin.com豆丁网 ryptamine receptor,5-HT): 5-HT 2 、5-HT 3 、5-HT 4 ,神经激肽受体(neurokinin receptor,NK):NK 1 、NK 3 、 血管活性肠肽受体(vasoactive intestinal pepti..
基于8个网页-相关网页
P物质主要是通过与相应神经激肽受体(neurokinin-1 receptors,NK-1R)结合,介导G蛋白偶联的第二信号途径而发挥作用的。
基于4个网页-相关网页
神经激肽B受体抗体 Anti-NKR
神经激肽B受体 Neurokinin B receptor
神经激肽-B受体抗体 Anti-NKR/Neurokin B receptor
神经激肽B及其受体 neurokinin B receptor ; NKR
目的研究神经激肽3受体(NK 3r)在胰腺癌组织中的表达,并将结果结合临床资料分析,以期找出其中相关性。
Objective to investigate the expression of neurokinin-3 receptor (NK-3R) in pancreatic cancer and evaluate the relationship between expression of this receptor and clinical aspect.
本发明涉及某些喹啉化合物,其用作神经激肽- 1 (NK - 1)受体拮抗剂,和速激肽及特别是P物质抑制剂。
The present invention is directed to certain quinoline compounds which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance p.
本发明涉及某些内酰胺化合物,其适用作神经激肽- 1 (NK - 1)受体拮抗剂,速激肽特别是P物质抑制剂。
The present invention is directed to certain lactam compounds which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance p.
应用推荐